The prevalence of tuberculosis in Argentina has shown a generally decreasing trend over the past decade. In 2023, the value stood at 23.0 cases per hundred thousand persons. The year-on-year variation from 2022 to 2023 was -4.17%. Over the last two years (2022-2023), the variation has been -4.17% and +0% respectively. The Compound Annual Growth Rate (CAGR) over the last five years has been -2.42%. Looking ahead to the forecasted period, the prevalence is expected to continue declining, with a forecast five-year CAGR of -1.89%, resulting in an estimated drop to 20.0 cases per hundred thousand persons by 2028.
Future trends to watch for:
- Continued improvements in healthcare and tuberculosis prevention programs.
- Potential impacts of socioeconomic factors on disease prevalence.
- Emergence of drug-resistant tuberculosis strains.
- Effects of public health policies and international aid on disease control.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...